Literature DB >> 23722707

Obesity accentuates circadian variability in breathing during sleep in mice but does not predispose to apnea.

Eric M Davis1, Landon W Locke, Angela L McDowell, Patrick J Strollo, Christopher P O'Donnell.   

Abstract

Obesity is a primary risk factor for the development of obstructive sleep apnea in humans, but the impact of obesity on central sleep apnea is less clear. Given the comorbidities associated with obesity in humans, we developed techniques for long-term recording of diaphragmatic EMG activity and polysomnography in obese mice to assess breathing patterns during sleep and to determine the effect of obesity on apnea generation. We hypothesized that genetically obese ob/ob mice would exhibit less variability in breathing across the 24-h circadian cycle, be more prone to central apneas, and be more likely to exhibit patterns of increased diaphragm muscle activity consistent with obstructive apneas compared with lean mice. Unexpectedly, we found that obese mice exhibited a greater circadian impact on respiratory rate and diaphragmatic burst amplitude than lean mice, particularly during rapid eye movement (REM) sleep. Central apneas were more common in REM sleep (42 ± 17 h(-1)) than non-REM (NREM) sleep (14 ± 5 h(-1)) in obese mice (P < 0.05), but rates were not different between lean and obese mice in either sleep state. Even after experimentally enhancing central apnea generation by acute withdrawal of hypoxic chemoreceptor activation during sleep, central apnea rates remained comparable between lean and obese mice. Last, we were unable to detect patterns of diaphragmatic burst activity suggestive of obstructive apnea events in obese mice. In summary, obesity does not predispose mice to increased occurrence of central or obstructive apneas during sleep, but does lead to a more pronounced circadian variability in respiration.

Entities:  

Keywords:  central sleep apnea; circadian variability; control of breathing; obesity; obstructive sleep apnea

Mesh:

Year:  2013        PMID: 23722707      PMCID: PMC3742947          DOI: 10.1152/japplphysiol.00330.2013

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  39 in total

1.  Phenotypic differences in the hemodynamic response during REM sleep in six strains of inbred mice.

Authors:  Matthew J Campen; Yugo Tagaito; Todd P Jenkins; Philip L Smith; Alan R Schwartz; Christopher P O'Donnell
Journal:  Physiol Genomics       Date:  2002-12-03       Impact factor: 3.107

2.  A model of sleep-disordered breathing in the C57BL/6J mouse.

Authors:  Y Tagaito; V Y Polotsky; M J Campen; J A Wilson; A Balbir; P L Smith; A R Schwartz; C P O'Donnell
Journal:  J Appl Physiol (1985)       Date:  2001-12

3.  Periodic breathing in the mouse.

Authors:  Fang Han; Shyam Subramanian; Edwin R Price; Joseph Nadeau; Kingman P Strohl
Journal:  J Appl Physiol (1985)       Date:  2002-03

4.  Anatomic and physiologic predictors of apnea severity in morbidly obese subjects.

Authors:  Robert B Fogel; Atul Malhotra; Georgia Dalagiorgou; Malcolm K Robinson; Marianna Jakab; Ron Kikinis; Stephen D Pittman; David P White
Journal:  Sleep       Date:  2003-03-15       Impact factor: 5.849

5.  Effects of leptin and obesity on the upper airway function.

Authors:  Mikhael Polotsky; Ahmed S Elsayed-Ahmed; Luis Pichard; Christopher C Harris; Philip L Smith; Hartmut Schneider; Jason P Kirkness; Vsevolod Polotsky; Alan R Schwartz
Journal:  J Appl Physiol (1985)       Date:  2012-02-16

6.  Sleep apnea and effect of chemostimulation on breathing instability in mice.

Authors:  Akira Nakamura; Yasuichiro Fukuda; Tomoyuki Kuwaki
Journal:  J Appl Physiol (1985)       Date:  2002-10-25

7.  Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains.

Authors:  B A Taylor; C Wnek; D Schroeder; S J Phillips
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

Review 8.  Using mouse models to dissect the genetics of obesity.

Authors:  Gudrun A Brockmann; Marianna R Bevova
Journal:  Trends Genet       Date:  2002-07       Impact factor: 11.639

9.  Impact of interrupted leptin pathways on ventilatory control.

Authors:  Vsevolod Y Polotsky; Marc C Smaldone; Matthew T Scharf; Jianguo Li; Clarke G Tankersley; Philip L Smith; Alan R Schwartz; Christopher P O'Donnell
Journal:  J Appl Physiol (1985)       Date:  2003-10-24

10.  Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia.

Authors:  Barry W Row; Leila Kheirandish; Jennifer J Neville; David Gozal
Journal:  Pediatr Res       Date:  2002-09       Impact factor: 3.756

View more
  5 in total

Review 1.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

2.  Free-running circadian breathing rhythms are eliminated by suprachiasmatic nucleus lesion.

Authors:  Benton S Purnell; Gordon F Buchanan
Journal:  J Appl Physiol (1985)       Date:  2020-06-05

3.  Effects of orexin 2 receptor activation on apnea in the C57BL/6J mouse.

Authors:  Michael W Moore; Afaf Akladious; Yufen Hu; Sausan Azzam; Pingfu Feng; Kingman P Strohl
Journal:  Respir Physiol Neurobiol       Date:  2014-06-11       Impact factor: 1.931

4.  Brown Norway and Zucker Lean rats demonstrate circadian variation in ventilation and sleep apnea.

Authors:  Anne M Fink; Irina Topchiy; Michael Ragozzino; Dionisio A Amodeo; Jonathan A Waxman; Miodrag G Radulovacki; David W Carley
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

5.  Sleep phenotype in the Townes mouse model of sickle cell disease.

Authors:  Brett J O'Donnell; Lanping Guo; Samit Ghosh; Faraaz A Shah; Patrick J Strollo; Bryan J McVerry; Mark T Gladwin; Solomon F Ofori-Acquah; Gregory J Kato; Christopher P O'Donnell
Journal:  Sleep Breath       Date:  2018-08-29       Impact factor: 2.816

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.